Integrity Capital Management (HK)’s Eucrates Biomedical Acquisition Corp. Unit EUCRU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-3,800
Closed -$37K 79
2022
Q1
$37K Buy
+3,800
New +$37K 0.19% 93